Medicines Company

YTD

ALL

Why Robinhood?

You can watch MDCO and buy or sell other stocks, ETFs, and their options commission-free!

About MDCO

The Medicines Company is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax(R) (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex(R) (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable.

CEO

Mark Timney, MD, PhD

CEOMark Timney, MD, PhD

Employees

—

Employees—

Headquarters

Parsippany, New Jersey

HeadquartersParsippany, New Jersey

Founded

1996

Founded1996

Employees

—

Employees—

MDCO Key Statistics

Market cap

6.79B

Market cap6.79B

Price-Earnings ratio

-27.32

Price-Earnings ratio-27.32

Dividend yield

—

Dividend yield—

Average volume

3.12M

Average volume3.12M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$84.98

52 Week high$84.98

52 Week low

$18.83

52 Week low$18.83